✦ LIBER ✦

818 VIRAL KINETICS AND PHARMACODYNAMICS OF ALBINTERFERON ALFA-2B IN INTERFERON TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1, CHRONIC HEPATITIS C

✍ Scribed by A.U. Neumann; L. Rozenberg; V.G. Bain; J.G. McHutchison; E. Pulkstenis; G.M. Subramanian

Book ID: 117376744
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 59 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60820-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Albinterferon alfa-2b dosed every two or

Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C

✍ Stefan Zeuzem; Eric M. Yoshida; Yves Benhamou; Stephen Pianko; Vincent G. Bain; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

The efficacy and safety of albinterferon alfa-2b (alb-IFN), a novel recombinant protein consisting of interferon alfa-2b genetically fused to human albumin, was evaluated in a phase 2b, open-label study of patients with genotype 1, chronic hepatitis C. In all, 458 IFN-alfa treatment-naı ¨ve patients

848 VIRAL KINETICS DURING TREATMENT WITH

848 VIRAL KINETICS DURING TREATMENT WITH A CONTROLLED-RELEASE RECOMBINANT INTERFERON ALFA 2B IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

✍ E. Herrmann; S. Zeuzem; I. Dzyublyk; L. Moroz; I. Zaytsev; S. Martens; E.J. van 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

819 HEALTH-RELATED QUALITY OF LIFE (HRQO

✍ S. Pianko; E. Yoshida; S. Zeuzem; Y. Benhamou; V. Bain; E. Pulkstenis; J.G. McHu 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Two doses of PEG-interferon alfa-2b plus

Two doses of PEG-interferon alfa-2b plus rivabirin in genotype 1 naive patients with chronic hepatitis

✍ Marma Buti; Y. Lurie; Francisco Sanchez; Auristela Valdes; Maria Martell; Rafael 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

817 POSITIVE PREDICTIVE VALUE OF EARLY A

817 POSITIVE PREDICTIVE VALUE OF EARLY ANTIVIRAL RESPONSE PROFILE WITH ALBINTERFERON ALFA-2B IN IFN-NAIVE PATIENTS WITH GENOTYPE 1, CHRONIC HEPATITIS C

✍ A.U. Neumann; S. Zeuzem; E. Yoshida; Y. Benhamou; S. Pianko; J.G. McHutchison; E 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Pharmacodynamics of peginterferon alfa-2

Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study

✍ R. BRUNO; P. SACCHI; C. SCAGNOLARI; F. TORRIANI; L. MAIOCCHI; S. PATRUNO; F. BEL 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB